News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Tmunity signs licensing deal for pediatric brain cancer immunotherapy


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

There is a desperate need for this. I wish them luck and will be watching closely.  Dr Okada is on our medical advisory board and is one of the world experts on this topic.


Posted on: 05/03/2019

Tmunity signs licensing deal for pediatric brain cancer immunotherapy

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740